On March 25, the Senate approved a $2 trillion stimulus package, the Coronavirus Aid, Relief, and Economic Security Act, to address the economic and health impacts of the COVID-19 pandemic. The bill now moves to the House for...more
Last Friday, President Trump declared the spread of COVID-19 to be a national emergency, ushering in new flexibilities for federal health care programs to address the crisis. Within hours of the announcement, the Centers for...more
On Thursday, Jan. 30, the Centers for Medicare and Medicaid Services (CMS) released the Healthy Adult Opportunity initiative, long-awaited guidance that would enable states to convert Medicaid funding into a block grant for...more
House and Senate lawmakers came to a bipartisan agreement on an end-of-year spending deal that will fund the government for FY 2020. The $1.37 trillion package includes a total of $738 billion in funding for the military and...more
The past year has seen a veritable tidal wave of consumer product marketing claiming that cannabidiol (CBD) infused or derived products cure or treat cancer, epilepsy, anxiety, inflammation, diabetes, Alzheimer’s disease,...more
12/9/2019
/ Cannabidiol (CBD) oil ,
Cannabis Products ,
Comment Period ,
Dietary Supplements ,
Farm Bill ,
FDA Warning Letters ,
Federal Food Drug and Cosmetic Act (FFDCA) ,
Food and Drug Administration (FDA) ,
Health and Safety ,
Health Claims ,
Public Comment ,
Regulatory Requirements
On Friday, Sept. 27, President Trump signed a continuing resolution (CR) to fund the government at current levels until Nov. 21. This extended funding for the 20 health care programs that were set to expire at the end of the...more
The most recent proposal in a series of efforts by the Trump administration to increase price transparency in health care is one that may eventually require hospitals and providers to publicly disclose the payer-negotiated...more